Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s “Whole Hearted” Approach To Cardiac Device Research

This article was originally published in The Gray Sheet

Executive Summary

FDA’s Biophysics Lab is performing cardiac electrophysiology research aimed at improving industry’s clinical studies.

You may also be interested in...

FDA Research Labs See Spike In Pre-Market Consultation Requests

FDA’s Office of Science and Engineering Laboratories provided 12% more consults on pre-market issues in 2011 than the year before.

FDA, Industry Seek Better Computer Models For Cardio Device Development

FDA wants to better understand computer modeling methods - such as programs that simulate the performance of heart valves in the body - and help companies incorporate such tests into pre-market device applications

Coronavirus Update: Novartis Targets COVID-19 Cytokine Storm With Jakavi

Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts